Search

for
Search:

GlossaryUpadacitinib

medication that inhibits enzymes to treat autoimmune conditions

Upadacitinib is a medication that belongs to a class of drugs known as Janus kinase (JAK) inhibitors. It works by blocking specific enzymes involved in the inflammatory process, making it useful for treating autoimmune conditions like rheumatoid arthritis and, more recently, certain types of alopecia (hair loss).

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 65 results

Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib: A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata

research Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib: A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata

9 citations, January 2023 in “Dermatology and therapy”

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

research Upadacitinib for the Treatment of Alopecia Areata and Severe Atopic Dermatitis in a Pediatric Patient: A Case Report

7 citations, January 2022 in “SAGE open medical case reports”

Upadacitinib successfully treated a child's severe skin and hair loss issues.

research Treatment of Alopecia Areata With the Janus Kinase Inhibitor Upadacitinib: A Retrospective Cohort Study

6 citations, February 2023 in “Journal of the American Academy of Dermatology”

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

research Upadacitinib for Management of Recalcitrant Alopecia Areata: A Retrospective Case Series

3 citations, March 2023 in “JAAD case reports”

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

research Improvement of Recalcitrant Dissecting Cellulitis of the Scalp After a Trial of Upadacitinib

1 citations, January 2024 in “Curēus”

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

View more "upadacitinib" in research →

Community Join

0 / 0 results

— no results